CNS & Neurological Disorders - Drug Targets
Title:Commentary-1 (Research Highlights: USP30 Regulates the Mitophagy-Mediated Neuroprotection in Parkinson’s Disease)
Volume: 13 Issue: 10
Author(s): Rajanikant G. Krishnmurthy and Fayaz M. Shradgan
Affiliation:
Export Options
About this article
Cite this article as:
Krishnmurthy G. Rajanikant and Shradgan M. Fayaz, Commentary-1 (Research Highlights: USP30 Regulates the Mitophagy-Mediated Neuroprotection in Parkinson’s Disease), CNS & Neurological Disorders - Drug Targets 2014; 13 (10) . https://dx.doi.org/10.2174/1871527314666141226122809
DOI https://dx.doi.org/10.2174/1871527314666141226122809 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent Review on Network-based Elderly Healthcare System in the US
Recent Patents on Computer Science Progress in Multiple Sclerosis Genetics
Current Genomics STIP Regulates ERK1/2 Signaling Pathway Involved in Interaction with PP1γ in Lymphoblastic Leukemia
Current Molecular Medicine Physiological Insights Derived from Mathematical Models of Respiration
Current Respiratory Medicine Reviews New Perspectives on Acetaminophen
Current Cardiology Reviews Long-term Outcomes of Cerebral Venous Sinus Stenosis Corrected by Stenting
Current Neurovascular Research Prevalence of Neuropsychiatric Symptoms in Alzheimers Disease and Vascular Dementia
Current Alzheimer Research Subject Index to Volume 3
Current Drug Targets - CNS & Neurological Disorders Erratum
Current Neurovascular Research The Shock of the New: Progress in Schizophrenia Genomics
Current Genomics REM Sleep Behavior Disorder and Narcolepsy
CNS & Neurological Disorders - Drug Targets MicroRNAs in Tumorigenesis
Current Pharmaceutical Biotechnology Cyclooxygenase-2 Biology
Current Pharmaceutical Design Bacterial Zinc Proteases and their Inhibition
Current Enzyme Inhibition Neuropeptides as Therapeutic Targets to Combat Stress-Associated Behavioral and Neuroendocrinological Effects
CNS & Neurological Disorders - Drug Targets Mechanistic Insights into Mode of Action of a Potent Natural Antagonist of Orexin Receptor-1 by Means of High Throughput Screening and Molecular Dynamics Simulations
Combinatorial Chemistry & High Throughput Screening Exploring the Evidence Implicating the Renin-Angiotensin System (RAS) in the Physiopathology of Mood Disorders
Protein & Peptide Letters Mitochondrial Dynamics and Proteins Related to Neurodegenerative Diseases
Current Protein & Peptide Science Triazole and Oxadiazole Containing Natural Products: A Review
The Natural Products Journal A Novel Dynamic Analysis of Mental Status Linked to Biogenic Amines and Psychopathology
Current Psychiatry Reviews